[ad_1] HAYWARD, Calif., Nov. 11, 2024 /PRNewswire/ — Avirmax’s Chief Executive and Scientific Officer, Dr. Shengjiang Shawn Liu, Ph.D., will chair the upcoming session of “Acceleration of AAV Gene Therapy for Ocular Diseases: Improving Delivery and […]

[ad_1] HAYWARD, Calif., Oct. 15, 2024 /PRNewswire/ — Avirmax Biopharma Inc. (ABI) team will attend AAO 2024, the American Academy of Ophthalmology’s annual meeting in Chicago, October 17-21, 2024. Avirmax will exhibit at booth #5357 to […]